Please note: AABB reserves the right to make updates to this program.
Wednesday, September 27, 2023
2:00 – 3:00 PM Eastern Time
Program Number: 23EL-878
Director: Samantha (Clem) Radtke, MLS(ASCP)cmSBBcm, Manager, Immunohematology Reference Laboratory, American Red Cross, Ft Wayne, IN
Moderator: Kerry O’Brien, MD, Blood Bank Medical Director, Beth Israel Deaconess Medical Center; Assistant Professor of Pathology, Harvard Medical School, Boston, MA
Antibody titrations can be helpful in-patient management in the setting of pregnancy, hematopoietic transplant, solid organ transplant, and in the work-up of complex antibody cases. Suzanne Davisson will focus on lab techniques for titrations and different applications of titrations, such as prenatal testing, DTT-treated plasma titrations for transplant, and identification of high-titer-low-avidity antibodies. Dr. Shainker will discuss the use of titers from the MFM perspective and how they use them to determine screening for fetal anemia. The speakers will discuss various titer techniques and their applications, provide more in-depth discussion of titer application in the prenatal setting and provide case studies.
After participating in this educational activity, participants should be able to:
Registration includes access to both the live and on-demand version of this eCast.
If you are a facility interested in participating in this eCast, simply complete the Group Viewing registration form and AABB will provide detailed instructions to share with your team approximately one week prior to the live program (each team member to register for the program utilizing a promocode). For single viewers, simply click on the Register button below to register.
Please note: registration for the live eCast will close 1 hour prior to the eCast start time. If you register after this time you will receive access to the on-demand eCast when it is available.
This activity is eligible for one (1) continuing education credit/contact hour for Physicians, Nurses (including California-based nursing professionals through CBRN), California Lab Personnel, Florida Lab Personnel and General Participation credit. AABB reserves the right to reduce or increase the number of credits granted based on the final activity duration. For more information on each credit type please visit our Continuing Education Credits webpage.
There is no financial support for this activity.
In support of improving patient care, this activity has been planned and implemented by the Association for the Advancement of Blood & Biotherapies (AABB) and CME Outfitters, LLC. CME Outfitters LLC. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME): CME Outfitters, LLC, designates this live activity for a maximum of one (1) AMA PRA Category 1 CreditTM. CME Outfitters, LLC, designates this enduring activity for a maximum of one (1) AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Live Activity - Upon completion of the live activity, you will receive instructions to complete your evaluation, which is necessary to claim credit and receive your certificate of attendance/completion (credit must be claimed by the date provided in the instructions). The evaluation can be found by logging into the AABB Education Platform.
Enduring Activity - Once the enduring (on-demand) program is available, you will receive instructions to access the AABB Education Platform. Upon completion of viewing the enduring activity, you will need to complete the evaluation, which is necessary to claim credit and receive your certificate of completion (credit must be claimed by the date provided in the AABB Education Platform).
Program & Credit Expiration Dates:
It is the policy of CME Outfitters, LLC, and the Association for the Advancement of Blood & Biotherapies to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that the presence of such relationships will have a negative impact on the presentations.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty, peer reviewers, and CME Outfitters, LLC. personnel are provided at the beginning of the program.
Suzanne Davisson has been an Immunohematology Reference Laboratory technologist for 18 years and has a special interest in teaching and training students and new technologists. She earned a Bachelor of Science in Molecular Genetics from The Ohio State University and her Specialist in Blood Banking certification while working at The American Red Cross in Columbus, Ohio. She has been with Versiti Indiana for the past 13 years in Indianapolis, where she lives with her husband, son and goldendoodle, Dakota.
Kerry O’Brien, MD, is currently the Medical Director of the Blood Bank at Beth Israel Deaconess Medical Center in Boston, MA. She also serves as Assistant Professor of Pathology at Harvard Medical School. After growing up in Massachusetts, Dr. O’Brien graduated from Boston University School of Medicine in 2002 and completed residency in Anatomic and Clinical Pathology at Madigan Army Medical Center in Tacoma, WA in 2007. She then served as an attending pathologist at that same hospital for 4 years. She completed her Transfusion Medicine fellowship at Puget Sound Blood Center in Seattle (which is now known as Bloodworks Northwest) in 2012 after leaving the military. Dr. O’Brien has been at Beth Israel Deaconess Medical Center since 2012, where in addition to her duties as a Blood Banker, she has been the Clinical Pathology Residency Director since February 2016 and the Blood Banking/Transfusion Medicine Fellowship Program Director since 2019.
Scott Shainker, DO, MS, is a maternal-fetal medicine specialist in the Department of Obstetrics and Gynecology at Beth Israel Deaconess Medical Center (BIDMC). He is an Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School. In 2018 he became the first incumbent of the Annie and Chase Koch Chair in the Department of Obstetrics and Gynecology at BIDMC, an honor he continues to hold. Dr. Shainker completed his residency in Obstetrics and Gynecology at Boston Medical Center/Boston University School of Medicine and his fellowship in Maternal-Fetal Medicine at Beth Israel Deaconess Medical Center/Harvard Medical School. His research focuses on ultrasound markers and biomarker discovery for placenta accreta spectrum. Dr. Shainker is the co-founder and director of the New England Center for Placental Disorders, an international referral center for patients with placenta accreta spectrum and other complex placental disorders.